Cannabis for Migraines: Promising Results from UK Study
- 4 days ago
- 1 min read
Research Summary
A recent study published in Brain and Behavior explores the efficacy and safety of cannabis-based medicinal products (CBMPs) for treating migraines. Using data from the UK Medical Cannabis Registry, researchers observed improvements in health-related quality of life measures, such as headache impact, anxiety, sleep quality, and overall health status, over 24 months. Improvements in migraine disability were noted up to 12 months. Of the 203 adult participants, 15% reported adverse events, mostly mild to moderate. Higher THC doses correlated with better outcomes, though findings suggest caution due to wide confidence intervals. While promising, further randomized controlled trials are needed.
Study Details
👥 Research Team: Hooper L et al.
📚 Published In: Brain Behav
📅 Publication Date: 2026 Apr
⚕️ Medical Disclaimer: This summary is generated automatically from recent migraine research. Always consult with healthcare professionals for medical advice.